Integrated Biosimilar Atezolizumab Strategy
Translating biotech into accessible treatment.
1st Winner - Pharmaceutical Industrial Case Study
Problem
Biosimilar manufacturing requires cost efficiency. Cancer immunotherapy access varies globally. Indonesia's JKN system needs sustainable treatment strategies.
Overview
This industrial case study integrates continuous bioprocessing optimization, regulatory comparability frameworks, PD-L1 patient stratification, and JKN market-access strategy for biosimilar atezolizumab in NSCLC treatment.
Concept
A comprehensive industrial strategy optimizing biosimilar production through continuous bioprocessing while addressing patient stratification and healthcare system integration.
Scope
Biosimilar manufacturing strategy, continuous bioprocess optimization, regulatory comparability framework, PD-L1 patient stratification, cost-efficiency analysis, market-access strategy, and JKN integration.
Contribution
Developed collaboratively as part of a multidisciplinary team focused on pharmaceutical industrial innovation.
Reflection
This case highlighted how pharmaceutical strategy bridges scientific excellence, manufacturing efficiency, and equitable healthcare access.